Real-time enrollment status for this friedreich ataxia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:48 AM UTC
| NCT Number | NCT06628687 |
| Recruiting Status | Recruiting |
| Condition | Friedreich Ataxia |
| Phase | Clinical Trial |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Biogen |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06628687 is currently recruiting participants. This clinical trial study for friedreich ataxia is actively seeking new participants at 1 location across the United States. The study is sponsored by Biogen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06628687 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06628687 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.